Botox marketing puts Allergan in hot water (Morning Read)
Botox maker Allergan agreed Wednesday to pay $600 million to settle charges it illegally promoted and sold the beauty-enhancing drug through 2005 for unapproved uses like treating headaches, according to the New York Times.